Across Central Asia, particularly in Myanmar, the growing burden of cancer is creating an urgent need for accessible and effective oncology treatments. As the country continues strengthening its healthcare infrastructure, the demand for high-quality, affordable, and internationally compliant cancer medicines has increased significantly. Healthcare providers, pharmaceutical distributors, hospitals, and government procurement agencies are actively seeking